allulose glp 1 agonist Is a GLP-1 Agonist? Evidence and Key Differences GLP-1 release and vagal afferent

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore

More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

Although evidence from clinical trials has shown GLP-1 RAs to be safe and efficacious in people living with T2DM and renal impairment, their use is uncommon in this patient population

This review delves into the physiological roles of GLP-1, exploring its impact on ...